Verve Therapeutics, Inc. - VERV

SEC FilingsOur VERV Tweets

About Gravity Analytica

Recent News

  • 06.09.2025 - Goldman Sachs 46th Annual Global Healthcare Conference
  • 06.09.2025 - Goldman Sachs 46th Annual Global Healthcare Conference
  • 06.04.2025 - Jefferies Global Healthcare Conference
  • 06.04.2025 - Jefferies Global Healthcare Conference
  • 06.02.2025 - Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
  • 06.02.2025 - Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
  • 05.28.2025 - Verve Therapeutics to Participate in Upcoming Investor Conferences
  • 05.28.2025 - Verve Therapeutics to Participate in Upcoming Investor Conferences
  • 05.21.2025 - RBC Capital Markets Global Healthcare Conference
  • 05.21.2025 - RBC Capital Markets Global Healthcare Conference

Recent Filings

  • 05.14.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
  • 05.14.2025 - EFFECT Notice of Effectiveness
  • 05.14.2025 - EX-99.1 EX-99.1
  • 05.14.2025 - 8-K Current report
  • 04.29.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
  • 04.25.2025 - ARS Annual Report to Security Holders